Finance

Beta
Lists
SNSE:NASDAQ
Sensei Biotherapeutics Inc
$14.65
-11.75%
(-1.95) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNSE...
Open
$16.45
High
$17.58
Low
$14.01
Mkt. cap
19.66M
Avg. vol.
36.14K
Volume
50.83K
52-wk high
$36.76
52-wk low
$5.60
EPS
-$142.73
Beta
-0.24
Shares outstanding
1.34M
No. of employees
29
Open
$16.45
High
$17.58
Low
$14.01
Mkt. cap
19.66M
Avg. vol.
36.14K
Volume
50.83K
52-wk high
$36.76
52-wk low
$5.60
EPS
-$142.73
Beta
-0.24
Shares outstanding
1.34M
No. of employees
29
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to SNSE in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SNSE in the last 3 months.
Highest
Current $14.65
$55.00 (+275.43%)
Average
$52.50 (+258.36%)
Lowest
$50.00 (+241.30%)
News stories
From sources across the web
About Sensei Biotherapeutics Inc
CEO-
Employees29
Founded1999
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Websitesenseibio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.53M
2.54M
2.17M
150.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.67M
2.32M
2.79M
19.71M
Operating expense
5.21M
4.85M
4.96M
170.63M
Total operating expenses
5.21M
4.85M
4.96M
170.63M
Operating income
-5.21M
-4.85M
-4.96M
-170.63M
Other non operating income
-1.00K
-
-115.00K
-104.00K
EBT including unusual items
-4.94M
-4.57M
-4.72M
-170.24M
EBT excluding unusual items
-4.90M
-4.57M
-4.85M
-170.34M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.94M
-4.57M
-4.72M
-170.24M
Net profit margin
-
-
-
-
Earnings per share
-3.91
-
-
-
Interest and investment income
321.00K
289.00K
223.00K
392.00K
Interest expense
-10.00K
-6.00K
-3.00K
-
Net interest expenses
311.00K
283.00K
220.00K
392.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.17M
-4.82M
-4.92M
-170.60M
Gain or loss from assets sale
40.00K
1.00K
-21.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer